Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV001227065 | SCV001399403 | uncertain significance | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2025-01-13 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 1053 of the RELN protein (p.Gly1053Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with RELN-related conditions (PMID: 33004838). ClinVar contains an entry for this variant (Variation ID: 954581). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RELN protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |